Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07458204
Eligibility Criteria:
This study will include women:
* with histologically confirmed triple-negative breast cancer
* who have undergone neoadjuvant chemotherapy, regardless of the protocol used
* eligible for conservative surgery with sentinel lymph node biopsy or axillary lymph node dissection for whom surgery is performed under general anaesthesia
* with a ECOG status of 0 or 1
* of legal age
* affiliated with a social security system
* agreeing to participate in the study
The following women will not be included in the study:
* those with a history of allergy to local anaesthetics, regardless of class
* those with metastatic breast cancer
* those undergoing lumpectomy for breast cancer with histology other than triple negative
* undergoing total mastectomy
* those for whom the surgery is a repeat of the initial surgery
* with a personal history of breast cancer having a personal history of cancer (other than breast cancer) for which remission has not been achieved for at least 3 years
* minors
* protected by law (guardianship, curatorship, judicial protection)
* pregnant or breastfeeding
* refusing to participate in the study
Exclusion Criteria:
\-
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT07458204
Study Brief:
Protocol Section:
NCT07458204